ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 328186 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 328186; 2) Community: the network communities that were significantly associated with the response to NSC 328186; 3) Molecule: the relationships between components within communities and NSC 328186; 4) MDR: the compounds that were significantly associated with the NSC 328186.

NSC Compound Enrichment Correlation
NSC 662123 Null 0.00845932736945076 0.3388629
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.00845932736945076 0.43972474
NSC 681639 Camptothecin Derivative 0.00845932736945076 0.35614714
NSC 697189 Null 0.00845932736945076 0.53556628
NSC 245398 Null 0.00845932736945082 -0.042537663
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0112425217758227 0.26178436
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0112425217758227 0.32625744
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.0112425217758227 0.26480517
NSC 26980 Mitomycin 0.0112425217758227 0.10508704
NSC 348894 Benzenesulfonamide, 4-[(9-acridinylmethyl)amino]-N-(aminoiminomethyl)- 0.0112425217758227 0.40743208
Total:59  Current:13    [First] [Prev] [Next] [Last]